Market Research Logo

Biocartis Group NV (BCART) - Product Pipeline Analysis, 2018 Uate

Summary

Biocartis Group NV (Biocartis) is a molecular diagnostics company that provides personalized medicine for patients through its molecular diagnostics. The company undertakes the development of diagnostics technology platforms for multiplexed detection of bio-analytes, with oncology as its key focus area. Its Idylla is a molecular diagnostics system that provides easy access to clinical molecular diagnostic information. Biocartis also offers a wide range of oncology assays such as Idylla BRAF Mutation Test, Idylla KRAS Mutation Test, Idylla EGFR Mutation Test and Idylla NRAS Mutation. The company has operations in Belgium and Switzerland. Biocartis is headquartered in Mechelen, Belgium.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Biocartis Group NV
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


  • Biocartis Group NV Company Overview
    • Biocartis Group NV Company Snapshot
    • Biocartis Group NV Pipeline Products and Ongoing Clinical Trials Overview
      • Table Biocartis Group NV Pipeline Products and Ongoing Clinical Trials Overview
      • Table Biocartis Group NV Pipeline Products by Equipment Type
      • Table Figure 1: Biocartis Group NV Pipeline Products by Equipment Type
      • Table Biocartis Group NV Pipeline Products by Indication
  • Biocartis Group NV – Pipeline Analysis Overview
    • Biocartis Group NV - Key Facts
      • Table Biocartis Group NV, Key Facts
    • Biocartis Group NV - Major Products and Services
      • Table Biocartis Group NV, Major Products and Services
    • Biocartis Group NV Pipeline Products by Development Stage
      • Table Figure 2: Biocartis Group NV Pipeline Products by Development Stage
      • Table Biocartis Group NV Number of Pipeline Products by Development Stage
      • Table Biocartis Group NV Pipeline Products Summary by Development Stage
  • Biocartis Group NV Pipeline Products Overview
    • EGFR Colon Cancer Test
      • EGFR Colon Cancer Test Product Overview
        • Table EGFR Colon Cancer Test - Product Status
        • Table EGFR Colon Cancer Test - Product Description
    • Idylla Blood Stream Infections Panel
      • Idylla Blood Stream Infections Panel Product Overview
        • Table Idylla Blood Stream Infections Panel - Product Status
        • Table Idylla Blood Stream Infections Panel - Product Description
    • Idylla ctEGFR Assay
      • Idylla ctEGFR Assay Product Overview
        • Table Idylla ctEGFR Assay - Product Status
        • Table Idylla ctEGFR Assay - Product Description
    • Idylla Extended KRAS Mutation Test
      • Idylla Extended KRAS Mutation Test Product Overview
        • Table Idylla Extended KRAS Mutation Test - Product Status
        • Table Idylla Extended KRAS Mutation Test - Product Description
    • Idylla Extended NRAS Mutation Test
      • Idylla Extended NRAS Mutation Test Product Overview
        • Table Idylla Extended NRAS Mutation Test - Product Status
        • Table Idylla Extended NRAS Mutation Test - Product Description
    • Idylla HPV Test - Head & Neck Cancer
      • Idylla HPV Test - Head & Neck Cancer Product Overview
        • Table Idylla HPV Test - Head & Neck Cancer - Product Status
        • Table Idylla HPV Test - Head & Neck Cancer - Product Description
    • Idylla Immuno Tx Panel Test
      • Idylla Immuno Tx Panel Test Product Overview
        • Table Idylla Immuno Tx Panel Test - Product Status
        • Table Idylla Immuno Tx Panel Test - Product Description
    • Idylla KRAS Mutation Test
      • Idylla KRAS Mutation Test Product Overview
        • Table Idylla KRAS Mutation Test - Product Status
        • Table Idylla KRAS Mutation Test - Product Description
    • Idylla Liquid Biopsy EGFR Mutation Assay
      • Idylla Liquid Biopsy EGFR Mutation Assay Product Overview
        • Table Idylla Liquid Biopsy EGFR Mutation Assay - Product Status
        • Table Idylla Liquid Biopsy EGFR Mutation Assay - Product Description
    • Idylla Liquid Biopsy Test - Breast Cancer
      • Idylla Liquid Biopsy Test - Breast Cancer Product Overview
        • Table Idylla Liquid Biopsy Test - Breast Cancer - Product Status
        • Table Idylla Liquid Biopsy Test - Breast Cancer - Product Description
    • Idylla Meningitis Assay
      • Idylla Meningitis Assay Product Overview
        • Table Idylla Meningitis Assay - Product Status
        • Table Idylla Meningitis Assay - Product Description
    • Idylla MERS Assay
      • Idylla MERS Assay Product Overview
        • Table Idylla MERS Assay - Product Status
        • Table Idylla MERS Assay - Product Description
    • Idylla MSI Test
      • Idylla MSI Test Product Overview
        • Table Idylla MSI Test - Product Status
        • Table Idylla MSI Test - Product Description
    • Idylla Multiplex Respiratory Panel
      • Idylla Multiplex Respiratory Panel Product Overview
        • Table Idylla Multiplex Respiratory Panel - Product Status
        • Table Idylla Multiplex Respiratory Panel - Product Description
    • Idylla Neuro Panel Test
      • Idylla Neuro Panel Test Product Overview
        • Table Idylla Neuro Panel Test - Product Status
        • Table Idylla Neuro Panel Test - Product Description
    • Idylla Neurological Disease Assay
      • Idylla Neurological Disease Assay Product Overview
        • Table Idylla Neurological Disease Assay - Product Status
        • Table Idylla Neurological Disease Assay - Product Description
    • Idylla NGS Prep Panel - Pan-Tumor
      • Idylla NGS Prep Panel - Pan-Tumor Product Overview
        • Table Idylla NGS Prep Panel - Pan-Tumor - Product Status
        • Table Idylla NGS Prep Panel - Pan-Tumor - Product Description
    • Idylla NRAS Mutation Test
      • Idylla NRAS Mutation Test Product Overview
        • Table Idylla NRAS Mutation Test - Product Status
        • Table Idylla NRAS Mutation Test - Product Description
    • Idylla NRAS-BRAF Mutation Test
      • Idylla NRAS-BRAF Mutation Test Product Overview
        • Table Idylla NRAS-BRAF Mutation Test - Product Status
        • Table Idylla NRAS-BRAF Mutation Test - Product Description
    • Idylla Retrieve - NGS Hotspot Panel Assay
      • Idylla Retrieve - NGS Hotspot Panel Assay Product Overview
        • Table Idylla Retrieve - NGS Hotspot Panel Assay - Product Status
        • Table Idylla Retrieve - NGS Hotspot Panel Assay - Product Description
    • Idylla Sepsis Assay
      • Idylla Sepsis Assay Product Overview
        • Table Idylla Sepsis Assay - Product Status
        • Table Idylla Sepsis Assay - Product Description
    • Idylla Solid Biopsy Test - Breast Cancer
      • Idylla Solid Biopsy Test - Breast Cancer Product Overview
        • Table Idylla Solid Biopsy Test - Breast Cancer - Product Status
        • Table Idylla Solid Biopsy Test - Breast Cancer - Product Description
    • Idylla Syndromic Immunocompromised Panel
      • Idylla Syndromic Immunocompromised Panel Product Overview
        • Table Idylla Syndromic Immunocompromised Panel - Product Status
        • Table Idylla Syndromic Immunocompromised Panel - Product Description
    • Idylla Syndromic Panel - Tropical Fever
      • Idylla Syndromic Panel - Tropical Fever Product Overview
        • Table Idylla Syndromic Panel - Tropical Fever - Product Status
        • Table Idylla Syndromic Panel - Tropical Fever - Product Description
    • Idylla System - Multiplex Companion Diagnostics Test
      • Idylla System - Multiplex Companion Diagnostics Test Product Overview
        • Table Idylla System - Multiplex Companion Diagnostics Test - Product Status
        • Table Idylla System - Multiplex Companion Diagnostics Test - Product Description
    • Idylla Viral Load Assay - HBV
      • Idylla Viral Load Assay - HBV Product Overview
        • Table Idylla Viral Load Assay - HBV - Product Status
        • Table Idylla Viral Load Assay - HBV - Product Description
    • Idylla Viral Load Assay - HCV
      • Idylla Viral Load Assay - HCV Product Overview
        • Table Idylla Viral Load Assay - HCV - Product Status
        • Table Idylla Viral Load Assay - HCV - Product Description
    • Idylla Viral Load Assay - HIV
      • Idylla Viral Load Assay - HIV Product Overview
        • Table Idylla Viral Load Assay - HIV - Product Status
        • Table Idylla Viral Load Assay - HIV - Product Description
    • SeptiCyte Triage
      • SeptiCyte Triage Product Overview
        • Table SeptiCyte Triage - Product Status
        • Table SeptiCyte Triage - Product Description
  • Biocartis Group NV - Key Competitors
  • Biocartis Group NV - Key Employees
    • Table Biocartis Group NV, Key Employees
  • Biocartis Group NV - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
      • Table Biocartis Group NV, Subsidiaries
  • Recent Developments
    • Biocartis Group NV, Recent Developments
      • Jul 17, 2018: Biocartis launches innovative Idylla MSI Assay
      • Jun 27, 2018: Study Reviewing 2,500 Performed Idylla Tests Shows Generation of Valid Results in 98.1% of Cases
      • May 28, 2018: Study Demonstrates Ability of Idylla EGFR Mutation Test to Produce a Result in 80% of Failed Next Generation Sequencing Lung Cancer Tests
      • May 17, 2018: Biocartis Group: Two Performance Studies on Idylla MSI Biomarkers Selected for Publication at ASCO Conference
      • Apr 26, 2018: Biocartis Q1 2018 Business Update
      • Mar 15, 2018: Biocartis Abstract on Performance Idylla ctRAS Liquid Biopsy Tests Selected for Oral Presentation at 2018 American Association for Cancer Research Meeting
      • Mar 01, 2018: Biocartis Announces 2017 Results and 2018 Outlook
      • Mar 01, 2018: Biocartis Establishes R&D Center in the US
      • Mar 01, 2018: European Union provides Biocartis with up to EUR 24m debt financing facility for infectious disease projects
      • Feb 26, 2018: EPD Obtains European Regulatory Approval for Its Cardiac Mapping and Navigation System
  • Appendix
    • Methodology
      • Table Glossary
    • About GlobalData
    • Contact Us
    • Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report